Mr. Muhammad Rasheed Khan Orakzai, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3400 Union Ave, Sheboygan, WI 53081 Phone: 920-802-2100 |
Adeel Pervez, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 |
Dr. Philip H Walker, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2414 Kohler Memorial Dr, Sheboygan, WI 53081 Phone: 920-457-4461 Fax: 920-459-1483 |
Tochukwu Hilary Igwe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3400 Union Ave, Sheboygan, WI 53081 Phone: 920-802-2100 Fax: 920-802-1500 |
Nicholas Gustafson, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1222 N 23rd St, Sheboygan, WI 53081 Phone: 920-457-6800 |
Tyler Qiu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 |
News Archive
With the chill of winter comes a spike in community-acquired pneumonia (CAP), which spreads more easily as people retreat indoors and come into close contact. The lung infection triggers persistent coughing, chest pain, fever, and difficulty breathing, and is particularly hard on the very young and the very old. In fact, pneumonia is the leading cause of hospitalization among U.S. children, with estimated medical costs of $1 billion annually.
Three decades have passed since gene therapy pioneer William W. Hauswirth, Ph.D., and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals.
Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the Case Western Reserve University and University Hospitals Harrington-McLaughlin Heart & Vascular Institute, has recently received a $4.7 million contract from the Defense Advanced Research Projects Agency to fund the development of a new class of drugs that will selectively dilate blood cells under hypoxia (lack of oxygen in the body's tissues) and thereby enhance soldiers' performance at high altitude.
Columbia University Medical Center researchers have shown that new, or "de novo," protein-altering mutations—genetic errors that are present in patients but not in their parents—play a role in more than 50 percent of "sporadic" —i.e., not hereditary—cases of schizophrenia.
› Verified 4 days ago